--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 26, 2007
PEDIATRIX MEDICAL GROUP, INC.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Florida 001-12111 65-0271219
---------------------------- ------------------------ -------------------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
1301 Concord Terrace
Sunrise, Florida 33323
--------------------------------------------------------------------------------
(Address of principal executive office)
Registrant's telephone number, including area code (954) 384-0175
--------------------------------------------------------------------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Item 8.01 Other Events.
On July 26, 2007, Pediatrix Medical Group, Inc. (the "Company") announced
that the Audit Committee of its Board of Directors has completed an independent
comprehensive review of the Company's stock option practices and reported its
findings to the Board of Directors. The Company announced the key findings of
the Audit Committee's review and related recommendations in a press release
attached hereto as Exhibit 99.1 and incorporated herein by reference.
ITEM 9.01 Financial Statements and Exhibits
(d) Exhibits.
99.1-- Press Release dated July 26, 2007.
--------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PEDIATRIX MEDICAL GROUP, INC.
Date: July 26, 2007 By: /s/ Karl B. Wagner
------------------------------------
Name: Karl B. Wagner
Title: Chief Financial Officer
--------------------------------------------------------------------------------
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press Release dated July 26, 2007